Sranan Gold Corp. (CSE: SRAN) (OTCQB: SRANF) (FSE: P84) (Tradegate: P84) (‘Sranan’ or the ‘Company’) is pleased to announce that it has entered into an option agreement (the ‘Agreement’) with Lawantino N.V. (the ‘Vendor’) to acquire up to a 100% interest in the 18,468-hectare Lawantino Gold Property (the ‘Property’) situated in southeastern Suriname. The acquisition of the Property, which is currently the focus of extensive artisanal alluvial mining (see Figure 1), strengthens Sranan’s position within the highly prospective Guiana Shield, a region recognized for structurally controlled gold mineralization. The Company now controls 47,500 hectares of high-potential land for exploration.

The Property is strategically located along the same deep-seated regional structure, the Central Guiana Shear Zone (CGSZ), that hosts Founders Metals’ Antino Gold Project and Miata Metals’ Sela Creek Project, two of the most active gold exploration projects in Suriname.

The Company has confirmed the presence of extensive active artisanal alluvial mining (see Figure 2) with multiple generations of mining (miners return to the same sites with more effective equipment). Sampling of limited saprolite exposure encountered shear-hosted quartz veins cutting granite near the contact with basaltic rocks. Two samples returned 4.24 and 1.88 grams per tonne gold, which are considered significant given the limited evaluation completed.

Oscar Louzada, Sranan’s CEO, stated: ‘The Lawantino acquisition is a strategic addition to our Suriname exploration portfolio, strengthening our position along a proven and highly prospective structural corridor. The Project benefits from favourable geology, clear evidence of gold endowment through ongoing artisanal mining, and proximity to two active gold exploration projects. Lawantino fits well with our disciplined growth strategy and complements our ongoing work at Tapanahony as we continue to build value through systematic exploration.’

Sranan’s initial exploration program will focus on integrating areas of artisanal mining with satellite interpretation, geological mapping, geochemical sampling, and structural analysis to prioritize targets for future trenching and drilling. The approach is to develop targets quickly and efficiently. A variety of lithologies observed in mine workings, including basalt, siltstone, and other metasediments, suggest a variety of potentially favourable lithologies and structures to test.

Auracle Geospatial Science Inc. (‘Auracle’) was contracted by Sranan to analyze the structural complexity of the Lawantino Property by means of its proprietary Mapped Underworld Dimension (MUD® SAR) remote-sensing system. Results from Auracle’s analysis show a distinct increase in fracture density in association with abundant small-scale miners (see Figure 3). A similar increase in fracture density is observed on the east portion of the Lawantino Property.

Lawantino Agreement Terms

Pursuant to the terms of the Agreement, dated February 5, 2026, Sranan may earn a 100% interest in the Property by making cash and share payments and completing exploration-related expenditures. Over a 5-year period, the Company may earn 90% interest in the Property by making total cash payments of US$1,900,000, issuing 1,800,000 common shares to the arm’s-length Vendor, and completing exploration expenditures on the Property totaling US$1,700,000. Upon completion of the 90% earn-in, the Vendor will retain a 10% interest in the Property and a 2% net smelter return royalty (‘NSR’) on all metals production from the Property. There was no finder fees paid.

Sranan may repurchase the 2% NSR for US$3.0 million and, upon the establishment of a minimum 750,000-ounce measured and indicated gold resource, may acquire the remaining 10% interest in the Property based on an independent valuation.

Table 1: Summary of Lawantino Property Agreement Earn-in Obligations

Figure 1. Location of the Lawantino Property, along the CGSZ, showing major drainages and areas of small-scale mining.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10997/283308_94a3d6ef64bd5aaa_001full.jpg

Figure 2. Scouting flight showing extensive, active alluvial mining (December 23, 2025)

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10997/283308_94a3d6ef64bd5aaa_002full.jpg

Figure 3. Fracture Density Image generated by Auracle using MUD® SAR. Red areas indicate more intense ground preparation favourable for gold. Active areas of small-scale mining in bright yellow. The CGSZ cuts southeast to northwest through the concession.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10997/283308_94a3d6ef64bd5aaa_003full.jpg

Dr. Dennis LaPoint, EVP of Exploration and Business Development, states, ‘I am very excited about this new acquisition along the same structural trend of the CGSZ that hosts two active gold exploration projects. Lawantino complements our ongoing drilling program at our Tapanahony Gold Project and demonstrates that Sranan will continue to expand our portfolio of gold projects based on our extensive knowledge of Suriname. The agreement with Lawantino N.V. represents a major step in expanding our footprint within Suriname’s highly prospective southeastern part of the Marowijne greenstone belt along one of the major controlling structures for large gold deposits. A strength of the Sranan team is our ability to develop early-stage projects into potential new discoveries. I first reviewed this area in 2007 when held by Canarc, so I am very pleased with our cooperation and relationship with Lawantino shareholders.’

Samples were prepared and assayed by Filab in Paramaribo, Suriname. All samples >2 g/t Au were re-assayed with 50-gram re-assay and gravimetric assay. Standard QA/QC procedures were followed and showed a satisfactory level of reproducibility. The Company notes that the drill intercepts may not represent true underlying mineralization. Core logging, photography, and sampling are completed under strict industry standard QA/QC protocols (Oreas certified reference materials, assayed coarse blanks, duplicates of core).

Qualified Person

Dr. Dennis J. LaPoint, Ph.D., P.Geo., a ‘qualified person’ as defined under National Instrument 43-101, has reviewed and approved the scientific and technical information contained in this release. Dr. LaPoint is not independent of Sranan Gold, as he is the Company’s EVP of Exploration and Corporate Development.

About Sranan Gold Corp.

Sranan is engaged in the business of mineral exploration and the acquisition of mineral property assets in Suriname. The Company’s flagship Tapanahony Project covers 29,000 hectares in one of Suriname’s most prolific artisanal gold mining districts.

For more information, please visit www.sranangold.com.

THE CANADIAN SECURITIES EXCHANGE HAS NOT APPROVED NOR DISAPPROVED THE CONTENT OF THIS PRESS RELEASE.

Forward-looking Statements

Certain statements in this release constitute ‘forward-looking statements’ or ‘forward-looking information’ within the meaning of applicable securities laws, including, without limitation, the successful completion of the acquisition of the Lawantino Gold Project as discussed in this press release, the timing, nature, scope and details regarding the Company’s exploration plans and results at its projects. Such statements and information involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company, its projects, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. Such statements can be identified by the use of words such as ‘may’, ‘would’, ‘could’, ‘will’, ‘intend’, ‘expect’, ‘believe’, ‘plan’, ‘anticipate’, ‘estimate’, ‘scheduled’, ‘forecast’, ‘predict’ and other similar terminology, or state that certain actions, events or results ‘may’, ‘could’, ‘would’, ‘might’ or ‘will’ be taken, occur or be achieved. These statements reflect the Company’s current expectations regarding future events, performance and results and speak only as of the date of this release. Further details about the risks applicable to the Company are contained in the Company’s public filings available on SEDAR+ (www.sedarplus.ca), under the Company’s profile.

Forward-looking statements and information contained herein are based on certain factors and assumptions regarding, among other things, the estimation of mineral resources and reserves, the realization of resource and reserve estimates, metal prices, taxation, the estimation, timing and amount of future exploration and development, capital and operating costs, the availability of financing, the receipt of regulatory approvals, environmental risks, title disputes and other matters. While the Company considers its assumptions to be reasonable as of the date hereof, forward-looking statements and information are not guarantees of future performance and readers should not place undue importance on such statements as actual events and results may differ materially from those described herein. The Company does not undertake to update any forward-looking statements or information except as may be required by applicable securities laws.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/283308

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announced the publication of results from its Phase II ARCHER study in ESC Heart Failure, a journal of the European Society of Cardiology.

The peer-reviewed article reports results from a randomized, double-blind, placebo-controlled trial evaluating CardiolRx, Cardiol’s lead oral drug candidate, in 109 patients with acute myocarditis using advanced cardiac magnetic resonance (CMR) imaging measures of myocardial inflammation and remodelling.

In the study, treatment with CardiolRx produced a significant reduction in left ventricular mass versus placebo (-9.2 g; p=0.0117), along with a decrease in left atrial remodelling, and favorable trends across multiple markers of myocardial inflammation. CardiolRx was also shown to be safe and well tolerated. Reduction in left ventricular mass is widely considered consistent with decreased myocardial edema and inflammatory burden in myocarditis and improved clinical outcomes.

The biological signals observed in ARCHER are directly relevant to Cardiol’s ongoing pivotal Phase III MAVERIC trial in recurrent pericarditis. Myocarditis and pericarditis are inflammatory diseases of the myocardium and pericardium, respectively, and are recognized to fall within the spectrum of inflammatory myopericardial syndrome, an umbrella term describing the potential myocarditis-pericarditis overlap: similar causes, anatomical contiguous structures, and mixed forms with possible reciprocal involvement, such as myopericarditis and perimyocarditis.

‘This publication marks an important moment in the broader dissemination of CardiolRx’s therapeutic potential,’ said David Elsley, President and Chief Executive Officer of Cardiol Therapeutics. ‘ARCHER provides additional compelling clinical evidence that CardiolRx impacts the underlying biology of inflammatory heart disease and reduces inflammation-driven structural damage in the heart, increasing our confidence in MAVERIC, which is focused on delivering meaningful outcomes for patients with recurrent pericarditis.’

The full paper is available at:
https://academic.oup.com/eschf/advance-article/doi/10.1093/eschf/xvaf034/8427108

About Cardiol Therapeutics

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. The Company’s lead small-molecule drug candidate, CardiolRx, modulates inflammasome pathway activation, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with pericarditis, myocarditis, and heart failure.

The MAVERIC Program is evaluating CardiolRx for the treatment of recurrent pericarditis, an inflammatory disease of the pericardium associated with symptoms including debilitating chest pain, shortness of breath, and fatigue, which can lead to physical limitations, reduced quality of life, emergency department visits, and hospitalizations. The program comprises the completed Phase II MAvERIC-Pilot study (NCT05494788) and the ongoing pivotal Phase III MAVERIC trial (NCT06708299). The U.S. FDA has granted Orphan Drug Designation to CardiolRx for the treatment of pericarditis, including recurrent pericarditis.

The ARCHER Program is also studying CardiolRx, specifically in acute myocarditis-an important cause of acute and fulminant heart failure in young adults and a leading cause of sudden cardiac death in individuals under 35 years of age. The program comprises the completed Phase II ARCHER study (NCT05180240), which evaluated the safety, tolerability, and efficacy of CardiolRx in this patient population.

The Company is also developing CRD-38, a novel, subcutaneously administered drug formulation intended for the treatment of inflammatory heart disease, including heart failure-a leading cause of death and hospitalization in the developed world, with associated healthcare costs in the United States exceeding US$30 billion per year.

For more information about Cardiol Therapeutics, please visit cardiolrx.com.

Cautionary statement regarding forward-looking information:

This news release contains ‘forward-looking information’ within the meaning of applicable securities laws. All statements, other than statements of historical fact, that address activities, events, or developments that Cardiol believes, expects, or anticipates will, may, could, or might occur in the future are ‘forward-looking information’. Forward looking information contained herein may include, but is not limited to statements regarding the Company’s focus on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, the Company’s intended clinical studies and trial activities and timelines associated with such activities, including the Company’s plan to complete the Phase III study in recurrent pericarditis with CardiolRx, the Company’s plan to advance the development of CRD-38, a novel subcutaneous formulation intended for the treatment of inflammatory heart disease, including heart failure, including through the initiation of the first-in-human clinical evaluation, and the Company’s belief that results from the ARCHER trial provide compelling clinical proof of concept for CardiolRx, strengthen the scientific and clinical rationale for Cardiol’s lead Phase III program in recurrent pericarditis. Forward-looking information contained herein reflects the current expectations or beliefs of Cardiol based on information currently available to it and is based on certain assumptions and is also subject to a variety of known and unknown risks and uncertainties and other factors that could cause the actual events or results to differ materially from any future results, performance or achievements expressed or implied by the forward looking information, and are not (and should not be considered to be) guarantees of future performance. These risks and uncertainties and other factors include the risks and uncertainties referred to in the Company’s Annual Information Form filed with the Canadian securities administrators and U.S. Securities and Exchange Commission on March 31, 2025, available on SEDAR+ at sedarplus.ca and EDGAR at sec.gov, as well as the risks and uncertainties associated with product commercialization and clinical studies. These assumptions, risks, uncertainties, and other factors should be considered carefully, and investors should not place undue reliance on the forward-looking information, and such information may not be appropriate for other purposes. Any forward-looking information speaks only as of the date of this press release and, except as may be required by applicable securities laws, Cardiol disclaims any intent or obligation to update or revise such forward-looking information, whether as a result of new information, future events, or results, or otherwise. Investors are cautioned not to rely on these forward-looking statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/283346

First drill testing of a large-scale Rossing-style uranium target, along trend of Namibia’s giant uranium deposits

ReeXploration Inc. (TSXV: REE) (FSE: K2I0) (‘ReeXploration’ or the ‘Company’) is pleased to announce the launch of a fully funded uranium drilling program at the Eureka Project in central Namibia. This campaign marks the Company’s first drill testing of a large-scale uranium target, 6.5 x 3.5 km in extent, defined through integrated geophysical, geochemical, and geological work. The target is located along trend of Namibia’s world renowned ‘Alaskite Alley’, a corridor hosting giant leucogranite-hosted uranium deposits.

The drill campaign will evaluate a range of priority zones distributed across the broader target area, selected on the basis of airborne and ground uranium radiometric responses, uranium-in-soil geochemistry, and interpreted favourable structural and lithological settings. The priority zones all fall within a regional geological setting consistent with leucogranite-hosted uranium systems elsewhere in Namibia’s Central Zone, including the Rössing, Husab, and Etango deposits.

The core drilling program is expected to include up to 2,000 metres of drilling across 12 to 15 drill holes, and will be results-driven. Drill holes are designed to test for primary leucogranite-hosted uranium mineralization below the weathering profile.

‘The start of drilling at Eureka marks a significant milestone for ReeXploration, representing our first drill program on a large and highly prospective uranium system,’ said Christopher Drysdale, Interim CEO of ReeXploration. ‘This initial campaign will evaluate several priority zones and generate critical information to refine our geological understanding and guide future exploration. Importantly, Eureka also hosts confirmed rare earth element mineralization, providing the Company with dual-commodity exposure and long-term strategic optionality. Operating in Namibia, with its proven history of supporting responsible exploration and development, significantly enhances our ability to advance and unlock the full potential of the Eureka Project.’

Figure 1: Regional satellite view showing the position of the uranium anomalies southwest of the Eureka Dome, and their proximity to the Welwitschia Lineament and other large uranium deposits in Alaskite Alley.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6102/282719_8ad182f6940f097b_001full.jpg

Program Overview and Next Steps

The initial drilling phase (up to 2,000 metres in 12 to 15 drill holes) is designed to provide first-pass testing of the uranium system at depth and to validate the geological model developed from recent radiometric surveys, soil geochemistry, and field mapping.

Priority zones for drill testing have been identified based on coincident:

• Airborne uranium radiometric anomalies
• High total gamma responses (>500 cps) from ground spectrometer surveys
• Uranium-in-soil anomalies (>10 ppm U) identified by pXRF analysis
• Interpreted leucogranites in contact with reactive calc-silicate host rocks

The zones include occurrences of visible secondary uranium mineralization identified within leucogranites and gypcretes/calcretes.

Drilling will consist of core drill holes designed to confirm the presence, style, and continuity of uranium mineralization at depth, and to improve the Company’s understanding of the broader uranium system across the Eureka Project area.

Figure 2: Company license holding showing REE targets within the Eureka Dome, and airborne uranium anomalies (Government Airborne Radiometrics) backdrop. Insert: Thorium radiometric backdrop showing low thorium relative to the uranium anomalies.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6102/282719_8ad182f6940f097b_002full.jpg

Qualified Person

Tolene Kruger, BSc. (Hons), M.Sc., is a consulting geologist and has reviewed and approved the scientific and technical information in this news release. Ms. Kruger is registered as Professional Natural Scientist (Pr.Sci.Nat.) with the South African Council for Natural Science Professions (SACNASP, Reg. No.: 148182), and a Qualified Person for the purposes of National Instrument 43-101 – Standards of Disclosure for Mineral Projects. Ms. Kruger is not independent of the Company under NI 43-101.

About ReeXploration Inc.

ReeXploration (TSXV: REE) (FSE: K2I0) is a Canadian exploration company positioned to help meet surging global demand for secure, responsible supplies of critical minerals essential to the clean energy transition, advanced technologies and national defense. The Company’s flagship Eureka Project in central Namibia pairs a technically proven rare earth foundation – supported by the production of a clean monazite concentrate – with a newly defined, high-priority uranium target located within one of the world’s most established uranium corridors. Together, these commodities provide multi-path discovery potential aligned with accelerating global efforts to diversify critical mineral and nuclear fuel supply. Supported by a Namibia-based technical team and guided by global critical minerals experts, ReeXploration is advancing a disciplined, discovery-led strategy, building a credible, ESG-aligned platform positioned to benefit from the global race to diversify and secure responsible supply chains.

Caution Regarding Forward Looking Information

This press release may contain forward-looking information. This information is based on current expectations and assumptions (including assumptions relating to general economic and market conditions) that are subject to significant risks and uncertainties that are difficult to predict. Actual results may differ materially from results suggested in any forward-looking information. ReeXploration does not assume any obligation to update forward-looking information in this release, or to update the reasons why actual results could differ from those reflected in the forward-looking information unless and until required by securities laws applicable to ReeXploration. Additional information identifying risks and uncertainties is contained in the filings made by ReeXploration with Canadian securities regulators, which filings are available at www.sedarplus.ca.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282719

(TheNewswire)

Vancouver, B.C. TheNewswire – February 9, 2026 Armory Mining Corp. (CSE: ARMY) (OTC: RMRYF) (FRA: 2JS) (the ‘Company’ or ‘Armory’) a resource exploration company focused on the discovery and development of minerals critical to the energy, security and defense sectors, is pleased to announce that is preparing to conduct a series of airborne geophysics surveys at the Ammo antimony-gold project (‘Ammo’) located in Nova Scotia, Canada.

The planned airborne geophysics surveys have been designed using efficient 50-meter flight lines (Fig 1) to collect information from associated sulfide mineralization, sericite and potassic alteration and probable pathfinder related uranium anomalies.

The Company intends on undertaking a magnetic survey designed to collect information regarding geological characteristics including structural and lithological features, an electromagnetic survey to collect data correlated with associated sulfide mineralization, and a radiometric survey to collect any possible correlation between uranium anomalies and the target mineralization.

‘These surveys form an important part of preliminary exploration critical to defining drill targets at Ammo,’ said Alex Klenman, CEO of Armory Mining. ‘The data generated by the surveys will aid tremendously in determining the best areas to drill.  The geological team has outlined a comprehensive exploration plan for the Ammo project, and we’re committed to completing these next steps,’ continued Mr. Klenman.  

Click Image To View Full Size

Figure 1 – Ammo Property and Significant Mining and Mineral Occurrences within and adjacent Distance

The Property

• The Company has the option to acquire a 100% interest in the Ammo Sb-Au project, comprising three contiguous mineral claims (Exploration Licenses) surrounding the historical West Gore antimony-gold mine, a past producer of antimony and gold, located in central Nova Scotia, Canada covering approximately 3,020 hectares (Fig. 2). 

• The property is underlain by sericitic slates and minor intercalated arenites of the Halifax formation, a member of the Ordovician Meguma Group. It is made up of a basal sandy flysch unit known as the Goldenville formation and an overlying shaly flysch unit known as the Halifax formation which hosts the West Gore gold-antimony mineralization. Peraluminous granites and minor mafic bodies intrude the Meguma Group sedimentary. This magmatic activity seems to be responsible for the hydrothermal activity that caused the gold mineralization (Fig 2). 

• The mineralization in adjacent West Gore mineralization occurs throughout the Meguma Group stratigraphy. The mineralization is generally in laterally continuous veins were emplaced during hydrofracturing in brittle ductile deformation dominated by quartz-carbonate gangue and iron sulphides with free gold, generally micron sized but nuggets up to 11 ounces have been reported. The sulfides with mineralization including Pyrite, pyrrhotite, arsenopyrite, stibnite, chalcopyrite, galena, sphalerite and iron oxides are associated with quartz-carbonate veins or sheared host rocks in the Mineralized zone. 

Click Image To View Full Size

Figure 2 – Ammo Property and Surrounding Mining and Mineral Occurrences

About Armory Mining Corp

Armory Mining Corp. is a Canadian exploration company focused on minerals critical to the energy, security and defense sectors. The Company controls an 80% interest in the Candela II lithium brine project located in the Incahuasi Salar, Salta Province, Argentina. In addition, the Company controls 100% interest in both the Ammo antimony-gold project located in Nova Scotia and the Riley Creek antimony-gold project located in British Columbia.

Qualified Person

The technical content of this news release has been reviewed and approved by Mr. Babak V. Azar, P.Geo., a qualified person as defined by National Instrument 43-101. Historical reports provided by the optionor were reviewed by the qualified person. The information provided has not been verified and is being treated as historic.

Contact Information

Alex Klenman

CEO & Director

alex@armorymining.com

604-970-4330

Neither the Canadian Securities Exchange nor its Market Regulator (as the term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy of accuracy of this news release.   This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the Company’s securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The Company’s securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the ‘1933 Act’) or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the  1933 Act) unless registered under the  1933 Act  and applicable  state  securities  laws, or an exemption from such registration requirements is available.

Forward-looking statements:

This press release contains certain forward-looking statements, including statements regarding the intended use of funds. The words ‘expects,’ ‘anticipates,’ ‘believes,’ ‘intends,’ ‘plans,’ ‘will,’ ‘may,’ and similar expressions are intended to identify forward-looking statements. Although the Company believes that its expectations as reflected in these forward-looking statements are reasonable, such statements involve risks and uncertainties. Actual results may differ materially from those expressed or implied in these statements due to various factors, including, but not limited to, political and regulatory risks in Canada, operational and exploration risks, market conditions, and the availability of financing. Readers are cautioned not to place undue reliance on forward-looking statements, which are made as of the date of this release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws.

Copyright (c) 2026 TheNewswire – All rights reserved.

(TheNewswire)

February 9, 2026 TheNewswire – Muskoka, Ontario Steadright Critical Minerals Inc. (CSE: SCM,OTC:SCMNF) (‘Steadright’ or the ‘Company’), a resource exploration company focused on advancing near‑term production opportunities, reports that from February 2nd 6th, 2026, members of the NSM Capital Sarl geological team from Morocco, together with a Canadian Earthworks contractor, were on site at the Copper Valley Copper Project to conduct field assessments in preparation for upcoming extraction activities.

The on‑site team evaluated the existing road network to determine haulage suitability and required upgrades for the planned movement of mineralized stockpiles. In addition, several test pits were examined to verify material characteristics and confirm extraction logistics for the initial phase of testing operations.

This fieldwork follows Steadright’s recent announcement that the former property owner, EMTF Sarl, had previously applied for a Mining License and Environmental Permit covering Exploration Permit No. 3843143, now being transferred into NSM Capital Sarl, a Morocco‑based company. Steadright’s Moroccan geological team expects receipt of the Mining License within the coming weeks. NSM Capital Sarl management has assumed responsibility for completing this process as expeditiously as possible.

Steadright holds a 75% interest in the common shares of NSM Capital Sarl through a shareholder agreement with Critical Foundation Metals Inc. (CFM), which holds the remaining 25%.

See Press Releases Dated January 8th, 2026 and January 20th, 2026.

Copper Valley, Copper-Lead-Silver Project, Morocco

Steadright CEO, Matt Lewis: ‘Our Moroccan team is indefatigable in their efforts. We are moving forward on our four properties in very, very good time and they should be quite proud. I encourage people to read about these efforts on our new website and in our new February Presentation (Deck), both of which can be found at www.steadright.ca.

ABOUT Steadright Critical Minerals INC.

Steadright Critical Minerals Inc. is a mineral exploration company established in 2019. Steadright has been focused since late spring 2025 on finding exploration and historical mining projects that can be brought into production within the Moroccan critical mineral space. Steadright currently has exposure through a Moroccan entity known as NSM Capital Sarl, with over 192 sq KMs of mineral exploration claims called the TitanBeach Titanium  Project, and found in the Southern Provinces of Morocco. Steadright has also recently signed a Binding MOU for the historic Goundafa Mine within the Kingdom of Morocco.

ON BEHALF OF THE BOARD OF DIRECTORS

For further information, please contact:

Matt Lewis

CEO & Director

Steadright Critical Minerals Inc.

Email: enquires@steadright.ca

Tel: 1-905-410-0587

www.steadright.ca

Neither the Canadian Securities Exchange (the ‘CSE’) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking information is subject to known and unknown risks, ‎uncertainties and other factors which may cause the actual results, level of activity, performance or ‎achievements of Steadright to be materially different from those expressed or implied by such forward-‎looking information. Such risks and other factors may include, but are not limited to: there is no ‎certainty that the ongoing programs will result in significant or successful ‎exploration and ‎development of Steadright’s properties; uncertainty as to ‎the actual results of exploration and ‎development or operational activities; uncertainty as to the availability and terms of ‎future financing on ‎acceptable terms; uncertainty as to timely availability of permits and other governmental approvals; ‎general business, economic, competitive, political and social uncertainties; capital market conditions ‎and market prices for securities, junior market securities and mining exploration company securities; ‎commodity prices; the actual results of current exploration and development or operational activities; ‎competition; changes in project parameters as plans continue to be refined; accidents and other risks ‎inherent in the mining industry; lack of insurance; delay or failure to receive board or regulatory ‎approvals; changes in legislation, including environmental legislation or income tax legislation, affecting ‎Steadright; conclusions of economic evaluations; and lack of qualified, skilled labour or loss of key ‎individuals.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the ‎securities in the United States. The securities have not been and will not be registered under the United ‎States Securities Act of 1933, as amended (the ‘U.S. Securities Act‘) or any state securities laws and ‎may not be offered or sold within the United States or to, or for the account or benefit of, U.S. Persons ‎unless registered under the U.S. Securities Act and applicable state securities laws, unless an ‎exemption from such registration is available.‎

Copyright (c) 2026 TheNewswire – All rights reserved.

• Drilling at the Road Cut Zone extends mineralisation more than 150 m down-dip along the Contact Zone Fault, including 11.0 m at 1.54 g/t Au from 380.0 m (KDD0142)

• Jagger Zone results confirm broad and continuous mineralisation at depth, highlighted by 13.0 m at 1.77 g/t Au and a high-grade interval of 2.0 m at 26.08 g/t Au (KDD0138)

• Mineralisation remains open at depth and along strike at both Jagger and Road Cut Zones as drilling advances toward resource definition

Kobo Resources Inc. (‘ Kobo’ or the ‘ Company ‘) ( TSX.V: KRI ) is pleased to report diamond drill results from six additional holes completed at the Jagger and Road Cut Zones at its 100%-owned Kossou Gold Project (‘ Kossou ‘) in Côte d’Ivoire. The results confirm depth continuity within the established shear systems and extend mineralisation along the Contact Zone Fault.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209917232/en/

Diamond Drill Results Highlights:

Road Cut Zone:

• KDD0142
  • 4.0 metres ( ‘ m’) at 2.39 g/t Au from 139.0 m
  • 6.0 m at 1.89 g/t Au from 232.0 m
  • 11.0 m at 1.54 g/t Au from 380.0 m
  • 5.0 m at 1.84 g/t Au from 395.0 m

Jagger Zone :

• KDD0138
  • 13.0 m at 1.77 g/t Au from 269.0 m, incl. 4.0 m at 3.32 g/t Au from 277.0 m
  • 2.0 m at 26.08 g/t Au from 342.0 m
• KDD0141
  • 22.0 m at 0.87 g/t Au from 270.0 m, incl. 14.0 m at 1.09 g/t Au from 279.0 m

Edward Gosselin, CEO and Director of Kobo commented: ‘These results continue to confirm the strength and continuity of gold mineralisation within both the Jagger and Road Cut shear systems at our Kossou Gold Project. At the Road Cut Zone, drilling has extended mineralisation more than 150 m down-dip along the Contact Zone Fault, reinforcing its significance as a key structural control. At the Jagger Zone, broad zones of mineralisation and high-grade intercepts at depth continue to demonstrate the scale and vertical continuity of the system. Importantly, we remain highly encouraged that mineralisation remains open, and we will continue our systematic drilling strategy to expand both zones as we advance toward resource definition in 2026.’

Road Cut Zone: KDD0142 Confirms Down-Dip Extension of Contact Zone Fault Mineralisation

KDD0142 was drilled on section RCZ600 to test the down-dip extension of gold mineralisation associated with the Contact Zone Fault and has successfully extended the system to more than 150 m below surface (see Figure 2).

The hole intersected multiple mineralised zones across the shear system, including 6.0 m at 1.89 g/t Au from 232.0 m , 11.0 m at 1.54 g/t Au from 380.0 m , and 5.0 m at 1.84 g/t Au from 395.0 m . These results build on earlier intersections from KDD0109 , which returned 10.0 m at 1.86 g/t Au from 204.0 m ( see news release dated October 30, 2025 ). To the north on section RCZ550, previous results include KDD0052 that returned multiple gold zones associated with the Contact Zone Fault shear system including 5.0 m at 1.01 g/t Au from 228.0, 6.0 m at 1.26 g/t Au from 244.0 m and 6.0 m at 1.94 g/t Au from 264.0 m (see press release dated January 13, 2025 for details).

Together, these results confirm depth continuity of mineralisation along the Contact Zone Fault target . These results further prioritize the Contact Zone Fault as a key mineralised structure at the Road Cut Zone. The area remains open along strike and at depth, and additional drilling is planned to further define and extend mineralisation to the north, south and down dip.

Jagger Zone: Broad Mineralised Zones Confirm Depth Continuity

Drill hole KDD0138 on section JZ750 intersected 13.0 m at 1.77 g/t Au from 269.0 m , confirming the continuation of mineralisation below KDD0100 , which returned 11.0 m at 1.26 g/t Au ( see news release dated October 30, 2025 ). These results extend gold mineralisation on the section to more than 150 m below surface .

The hole also intersected a narrow but high-grade structure, returning 2.0 m at 26.08 g/t Au from 342.0 m , demonstrating the presence of higher-grade individual structures within the broader Jagger Shear system (see Figures 3 and 4).

On section JZ900 , drill hole KDD0141 intersected a broad zone averaging 22.0 m at 0.87 g/t Au from 270.0 m , including 14.0 m at 1.09 g/t Au from 279.0 m , confirming continuity of the mineralised shear system to approximately 180 m below surface (see Figure 5). Drill hole KDD0123 , located immediately above, previously returned 7.0 m at 1.48 g/t Au and 4.0 m at 1.31 g/t Au ( see news release dated January 14, 2026 ), further supporting vertical continuity.

Mineralisation remains open at depth on both sections. Full assay results from all six holes are presented in Table 1.

Table 1: Summary of Significant Diamond Drill Hole Results

An accurate dip and strike and controls of mineralisation are unconfirmed and mineralised zones are reported as downhole lengths. Drill holes are planned to intersect mineralised zones perpendicular to interpreted targets. All intercepts reported are downhole distances, true widths are unknown.

Sampling, QA/QC, and Analytical Procedures

Drill core was logged and sampled by Kobo personnel at site. Drill cores were sawn in half, with one half remaining in the core box and the other half secured into new plastic sample bags with sample number tickets. Core samples are drilled using HQ core barrels to below the level of oxidation and then reduced to NQ core barrels for the remainder of the bore hole. Samples are transported to the SGS Côte d’Ivoire facility in Yamoussoukro by Kobo personnel where the entire sample was prepared for analysis (prep code PRP86/PRP94). Sample splits of 50 grams were then analysed for gold using 50g Fire Assay as per SGS Geochem Method FAA505. QA/QC procedures for the drill program include insertion of a certificated standards every 20 samples, a blank every 20 samples and a duplicate sample every 20 samples. All QAQC control samples returned values within acceptable limits.

Review of Technical Information

The scientific and technical information in this press release has been reviewed and approved by Paul Sarjeant, P.Geo., who is a Qualified Persons as defined in National Instrument 43-101. Mr. Sarjeant is the President and Chief Operating Officer and Director of Kobo.

About Kobo Resources Inc.

Kobo Resources is a growth-focused gold exploration company with a compelling gold discovery in Côte d’Ivoire, one of West Africa’s most prolific gold districts, hosting several multi-million-ounce gold mines. The Company’s 100%-owned Kossou Gold Project is located approximately 20 km northwest of the capital city of Yamoussoukro and is directly adjacent to one of the region’s largest gold mines with established processing facilities.

With over 31,000 metres of diamond drilling, nearly 5,887 metres of reverse circulation (RC) drilling, and 7,100+ metres of trenching completed since 2023, Kobo has made significant progress in defining the scale and prospectivity of its Kossou Gold Project. Exploration has focused on multiple high-priority targets within a 9+ km strike length of highly prospective gold-in-soil geochemical anomalies, with drilling confirming extensive mineralisation at the Jagger, Road Cut, and Kadie Zones. The latest phase of drilling has further refined structural controls on gold mineralisation, setting the stage for the next phase of systematic exploration and resource development.

Beyond Kossou, the Company is advancing exploration at its Kotobi Permit and is actively expanding its land position in Côte d’Ivoire with prospective ground, aligning with its strategic vision for long-term growth in-country. Kobo remains committed to identifying and developing new opportunities to enhance its exploration portfolio within highly prospective gold regions of West Africa. Kobo offers investors the exciting combination of high-quality gold prospects led by an experienced leadership team with in-country experience. Kobo’s common shares trade on the TSX Venture Exchange under the symbol ‘KRI’. For more information, please visit www.koboresources.com .

NEITHER THE TSXV NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSXV) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Cautionary Statement on Forward-looking Information:

This news release contains ‘forward-looking information’ and ‘forward-looking statements’ (collectively, ‘forward-looking statements’) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as ‘expects’, or ‘does not expect’, ‘is expected’, ‘anticipates’ or ‘does not anticipate’, ‘plans’, ‘budget’, ‘scheduled’, ‘forecasts’, ‘estimates’, ‘believes’ or ‘intends’ or variations of such words and phrases or stating that certain actions, events or results ‘may’ or ‘could’, ‘would’, ‘might’ or ‘will’ be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; and the delay or failure to receive board, shareholder or regulatory approvals. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, Kobo assumes no obligation and/or liability to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260209917232/en/

For further information:

Edward Gosselin
Chief Executive Officer and Director
1-418-609-3587
ir@kobores.com

Twitter: @KoboResources | LinkedIn: Kobo Resources Inc.